药物相关性颌骨坏死对比化脓性颌骨骨髓炎影像学及临床特点的研究

doi:10.13701/j.cnki.kqyxyj.2024.12.006

口腔医学研究 ›› 2024, Vol. 40 ›› Issue (12): 1065-1070.DOI: 10.13701/j.cnki.kqyxyj.2024.12.006

药物相关性颌骨坏死对比化脓性颌骨骨髓炎影像学及临床特点的研究

苏传超, 林梓桐, 王靖斐, 顾镇, 薛逸文, 邓润智^*

南京大学医学院附属口腔医院·南京市口腔医院口腔颌面外科,南京大学口腔医学研究所江苏南京 210008

收稿日期:2024-07-03 出版日期:2024-12-28 发布日期:2024-12-23
通讯作者: *邓润智,E-mail:docrod@163.com
作者简介:苏传超(1999~ ),男,安徽宣城人,住院医师,硕士在读,主要从事口腔颌面外科研究。

Study on Imaging and Clinical Features of MRONJ by Comparing with Suppurative Osteomyelitis of the Jaw

SU Chuanchao, LIN Zitong, WANG Jingfei, GU Zhen, XUE Yiwen, DENG Runzhi^*

Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing 210008, China

Received:2024-07-03 Online:2024-12-28 Published:2024-12-23

摘要/Abstract

摘要： 目的: 通过与化脓性颌骨骨髓炎进行对比,总结药物相关性颌骨坏死(medication-related osteonecrosis of the jaw,MRONJ)的影像学及临床特点。方法: 回顾性分析MRONJ与化脓性颌骨骨髓炎患者的影像学和临床资料。结果: MRONJ病例中:100%(对比化脓性颌骨骨髓炎的14.0%)见骨硬化,30.8%(对比5.0%)见多象限骨硬化,43.6%(对比4.0%)见死骨,25.6%(对比0%)见死骨伴多象限骨硬化;89.7%(对比20.0%)诱因是拔牙。结论: 相较于化脓性颌骨骨髓炎,MRONJ观察到骨硬化、多象限骨硬化和死骨影像表现的概率更高,多象限骨硬化伴死骨影像出现时提示其很可能是MRONJ;拔牙是MRONJ的最主要诱因。

Abstract: Objective: To summerize the imaging and clinical features of MRONJ (medication-related osteonecrosis of the jaw) by comparing with suppurative osteomyelitis of the jaw. Methods: The imaging and clinical data of patients with MRONJ were retrospectively analyzed with those of patients with suppurative osteomyelitis of the jaw. Results: In the cases of MRONJ, 100% (compared to 14.0% of suppurative osteomyelitis of the jaw) were observed with osteosclerosis, 30.8% (compared to 5.0%) were observed with multiquadrant osteosclerosis, 43.6% (compared to 4.0%) were observed with sequestrum, 25.6% (compared to 0%) were observed with sequestrum and multiquadrant osteosclerosis, and 89.7% (compared to 20.0%) of the inducements were tooth extraction. Conclusion: Compared to suppurative osteomyelitis of the jaw, the probability of oberving osteosclerosis, multiquadrant osteosclerosis, and sequestrum on MRONJ are higher, and when multiquadrant osteosclerosis and sequestrum appear simultaneously, it is very likely to be MRONJ. Tooth extraction is the most major inducement of MRONJ.

Key words: medication-related osteonecrosis of the jaw, biphosphonate, imagigng feature, sequestrum, osteosclerosis

苏传超, 林梓桐, 王靖斐, 顾镇, 薛逸文, 邓润智. 药物相关性颌骨坏死对比化脓性颌骨骨髓炎影像学及临床特点的研究[J]. 口腔医学研究, 2024, 40(12): 1065-1070.

SU Chuanchao, LIN Zitong, WANG Jingfei, GU Zhen, XUE Yiwen, DENG Runzhi. Study on Imaging and Clinical Features of MRONJ by Comparing with Suppurative Osteomyelitis of the Jaw[J]. Journal of Oral Science Research, 2024, 40(12): 1065-1070.

参考文献

[1] AlRowis R, Aldawood A, AlOtaibi M, et al. Medication-related osteonecrosis of the jaw(MRONJ): A review of pathophysiology, risk factors, preventive measures and treatment strategies[J]. Saudi Dent J, 2022, 34(3):202-210.
[2] Aguirre JI, Castillo EJ, Kimmel DB. Preclinical models of medication-related osteonecrosis of the jaw(MRONJ)[J]. Bone, 2021, 153(9):116-184.
[3] Kawahara M, Kuroshima S, Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review[J]. Int J Implant Dent, 2021, 7(1):47-58.
[4] Shin JW, Kim JE, Huh KH, et al. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw[J]. Sci Rep, 2024,14(1):8744-8753.
[5] Reinert CP, Pfannenberg C, Gückel B, et al. Preoperative assessment of medication-related osteonecrosis of the jaw using ¹⁸F fluoride positron emission tomography(PET)/CT and[¹⁸F] fluorodeoxyglucose PET/MRI in correlation with histomorphometry and micro-CT-A prospective comparative study[J]. Diagnostics(Basel), 2024, 14(4):428-443.
[6] Huber FA, Schumann P, von Spiczak J, et al. Medication-related osteonecrosis of the jaw-comparison of bone imaging using ultrashort echo-time magnetic resonance imaging and cone-beam computed tomography[J]. Invest Radiol, 2020, 55(3):160-167.
[7] Obermeier KT, Dewenter I, Malenova Y, et al. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw[J]. Sci Rep, 2024, 14(1):7914-7922.
[8] Zara S, De Colli M, di Giacomo V, et al. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts[J]. Clin Oral Investig, 2015, 19(3):601-611.
[9] Ruggiero SL, Dodson TB, Aghaloo T, et al. American association of oral and maxillofacial surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update[J]. J Oral Maxillofac Surg, 2022, 80(5):920-943.
[10] Shin JW, Kim JE, Huh KH, et al. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw[J]. Sci Rep, 2024, 14(1):8744-8753.
[11] Whitefield S, Ilan MB, Lazarovici TS, et al. Medication-related osteonecrosis of the jaw: A cross-sectional study on the prevalence of cutaneous manifestations and the primary care physician's role in its early diagnosis[J]. Am J Med, 2024, 137(3):266-272.
[12] Brauner E, Mezi S, Ciolfi A, et al. A new medical record proposal to the prognostic risk assessment for MRONJ in oncologic patients: "Sapienza head and neck unit" proposal[J]. Int J Environ Res Public Health, 2021, 18(4):1851.
[13] Tani M, Hatano K, Yoshimura A, et al. Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management[J]. Sci Rep, 2024, 14(1):13451-13461.
[14] Campisi G, Fedele S, Fusco V, et al. Epidemiology,clinical manifestations,risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents[J]. Future Oncol, 2014, 10(2):257-275.
[15] Al-Sarraj M, Burns M, Patel V. Pre-existing medication-related osteonecrosis of the jaw before dental extraction[J]. Br Dent J, 2023, 235(10):783-788.
[16] Jiang A, Zhang Z, Qiu X, et al. Medication-related osteonecrosis of the jaw(MRONJ): a review of pathogenesis hypothesis and therapy strategies[J]. Arch Toxicol, 2024, 98(3):689-708.
[17] Pippi R, Giuliani U, Tenore G, et al. What is the risk of developing medication-related osteonecrosis in patients with extraction sockets left to heal by secondary intention? A retrospective case series study[J]. J Oral Maxillofac Surg, 2021, 79(10):2071-2077.
[18] Dunphy L, Salzano G, Gerber B, et al. Medication-related osteonecrosis(MRONJ) of the mandible and maxilla[J]. Drug Ther Bull, 2020, 58(11):172-175.

编辑推荐 0

Metrics

阅读次数

全文

104

HTML			PDF

最新录用	在线预览	正式出版	最新录用	在线预览	正式出版
0	0	0	0	0	104

来源	本网站	其他网站

次数	72	32
比例	69%	31%

摘要

134

最新录用	在线预览	正式出版

0	0	134

	来源	本网站

	次数	134
	比例	100%

药物相关性颌骨坏死对比化脓性颌骨骨髓炎影像学及临床特点的研究

Study on Imaging and Clinical Features of MRONJ by Comparing with Suppurative Osteomyelitis of the Jaw

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐 0

Metrics

[1]	王松杰, 赵军方, 彭彦惠, 查治安, 王秋香, 孙强. 腮腺分泌性癌的临床表现及影像学特点[J]. 口腔医学研究, 2021, 37(11): 1039-1041.
[2]	马于斐, 赵志国, 黄怡怡, 刘维贤. 15例马德隆病的临床回顾分析[J]. 口腔医学研究, 2019, 35(11): 1052-1056.